The content on this site is intended for healthcare professionals only
As part of the Inclusive Cancer Care Research Equity (iCCaRE) for Black Men Consortium, Mr Arnold Merriweather (Prostate Cancer Survivor and Community Advocate, MPI, Florida, USA), Dr Che Ngufor (MPI, Mayo Clinic, Rochester, USA) and Dr Folakemi Odedina (MPI, Mayo Clinic, Florida, USA) introduce us to the consortium and discuss why it was setup, its aims and objectives and its potential impact in local and global communities.
A key strategy of the iCCaRE for Black Men Consortium is to address the disproportionate burden of prostate cancer seen in African American men via increased access to life-changing, scientific prostate cancer discoveries, especially those with implications for primary and secondary preventive interventions as well as information that will enhance access to prostate cancer clinical trials.
Here the panel discuss:
| What is iCCaRE | |
| Community Advisory Board | |
| Challenges and Barriers to Health Equity | |
| Improving quality of life | |
| ViRA filming | |
| Impact in the Black Community | |
| Wrap up |
Legislation – a powerful tool for promoting massive changes
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tackling breast cancer screening in conservative communities
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Introducing oncology to undergraduate medical and allied health sciences students
Genomic testing: Awareness and effective communication between healthcare professionals and patients
OncoAlert Round Up for September 15-21, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
